Skip to content

The effect of umbilical cord blood serum on improving disease symptoms in women with chronic cervicitis

Investigating the Effect of Umbilical Cord Blood Serum on Improving Disease Symptoms in Women with Chronic Cervicitis (A Quasi-Experimental Pilot Study)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251004067507N1
Enrollment
6
Registered
2025-10-17
Start date
2025-11-21
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic cervicitis. Inflammatory disease of cervix uteri

Interventions

Intervention 1: Intervention Group: 1 mL of serum obtained from umbilical cord blood is considered one unit. Initially, half a unit of serum is injected into the patient. After two days, if no adverse

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 45 Years

Inclusion criteria

Inclusion criteria: Married women with chronic cervicitis (definitively diagnosed by gynecological examination, Pap smear test, and colposcopy), with a history of multiple childbirths, aged 35 to 45 years, free from Heterotopic Ossification (H/O) disease (presence of bone in soft tissues), and unresponsive to common treatments such as repeated courses of topical and systemic antibiotics and probiotics, antiviral and antifungal treatments, and interventional procedures like cryosurgery for freezing abnormal cells, chemical cauterization for eradicating abnormal cells, diathermy, laser, LEEP, and finally, hysterectomy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Reduction in inflammation and skin lesions of the cervix. Timepoint: Once every two weeks. Method of measurement: Ultrasound.

Secondary

MeasureTime frame
Reduction in persistent foul-smelling discharge, dyspareunia, pelvic pain and pressure, low back pain, itching and burning, and post-coital bleeding. Timepoint: Once every two weeks. Method of measurement: Patient history.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Mansouri

Kermanshah University of Medical Sciences

Dr.nasrinmansouri@yahoo.com+98 83 3824 3500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026